Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The benefits and risks of alemtuzumab in multiple sclerosis.
Current and emerging therapies for multiple sclerosis.
Epidemiology of neurologically disabling disorders.
Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients.
Translation, cross-cultural adaptation and validation of the Portuguese version of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis.
Plasmocytoid dendritic cell deficit of early response to toll-like receptor 7 agonist stimulation in multiple sclerosis patients pDC deficit of early response to toll-like receptor 7 agonist stimulation.
Incidence and prevalence of multiple sclerosis in Europe: a systematic review.
Suppression of experimental autoimmune encephalomyelitis by interleukin-10 transduced neural stem/progenitor cells.
"Optic neuritis" that is neither.
Neuromyelitis optica-like pathology is dependent on Type I interferon response.
A subtraction pipeline for automatic detection of new appearing multiple sclerosis lesions in longitudinal studies.
Dynamic Assessment of Social Cognition in Individuals with Multiple Sclerosis: A Pilot Study.
Introduction: occupational therapy practice and research with persons with multiple sclerosis.
Matrix Metalloproteinase-8 Plays a Pivotal Role in Neuroinflammation by Modulating TNF-α Activation.
Management of Multiple Sclerosis in the Breastfeeding Mother.
Assessment of microRNA-related SNP effects in the 3' untranslated region of the IL22RA2 risk locus in multiple sclerosis.
[Relationship between biochemical parameters of cerebrospinal fluid and the course of multiple sclerosis.]
Systematic review of the influence of spasticity on quality of life in adults with chronic neurological conditions.
Hypercalcaemia and acute kidney injury following administration of vitamin D in granulomatous disease.
Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation.
Extensive White Matter Dysfunction in Cognitively Impaired Patients with Secondary-Progressive Multiple Sclerosis.
Dual task cost of walking is related to fall risk in persons with multiple sclerosis.
[Characteristics of coping strategies in patients with multiple sclerosis(review)].
Predictions for the future of kallikrein-related peptidases in molecular diagnostics.
Brain networks disconnection in early multiple sclerosis cognitive deficits: An anatomofunctional study.
Pages
« first
‹ previous
…
467
468
469
470
471
472
473
474
475
…
next ›
last »